📰 Groupa Streptococcus News
Groupa Streptococcus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Groupa Streptococcus. Real-time updates on events, politics, business and more.
June 11, 2024
Avidity Partners Management LP decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 24.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,137 shares of the company’s stock after selling 186,028 shares during the […]
June 6, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Halley E. Gilbert sold 18,200 shares of Vaxcyte stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $73.00, for a total value of $1,328,600.00. Following the transaction, the director now owns 5,625 shares in the company, valued at approximately […]
June 6, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $72.06, for a total transaction of $120,124.02. Following the sale, the senior vice president now owns 31,161 shares of the company’s stock, […]
June 6, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 2,616 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $188,508.96. Following the transaction, the chief executive officer now owns 144,746 shares in the company, valued […]
June 6, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $120,124.02. Following the transaction, the senior vice president now owns 31,161 shares in the company, […]
June 2, 2024
Eagle Asset Management Inc. trimmed its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.2% in the 4th quarter, Holdings Channel reports. The firm owned 354,123 shares of the company’s stock after selling 885 shares during the quarter. Eagle Asset Management Inc.’s holdings in Vaxcyte were worth $22,239,000 at the end of […]
May 31, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $69.43, for a total transaction of $1,041,450.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares […]
May 26, 2024
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Analyst Ratings This is a summary of recent recommendations […]
May 26, 2024
Westfield Capital Management Co. LP grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 45.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,455,593 shares of the company’s stock after buying an additional 451,677 shares during the quarter. […]
May 3, 2024
Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.